Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma

29 May 2013

Abstract excerpt

BACKGROUND: Excision repair cross-complementing gene-1 (ERCC1) and thymidylate synthase (TS) are key regulatory enzymes whose expression patterns are associated with overall survival (OS) in several malignancies. Their expression patterns and prognostic value in resected gastric adenocarcinoma (GAC) are not known. METHODS: In total, 109 patients who underwent resection for GAC between January 2000 and June 2011...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Treatments and Studies
Share to Gastric Cancer Management and Outcomes
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23719746
DOI: 10.1002/cncr.28175

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinomaPMID 23719746Read ↗

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.Semantic proximity Read ↗

Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.Semantic proximity Read ↗

Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers.Semantic proximity Read ↗

Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.Semantic proximity Read ↗

Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients.Semantic proximity Read ↗

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre studySemantic proximity Read ↗

ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung CancerSemantic proximity Read ↗

Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancerSemantic proximity Read ↗

Clinical importance of TYMS and ENOSF1 genetic variants and mRNA expression levels in response to chemotherapy in Iranian gastric cancer patientsSemantic proximity Read ↗

Association between polymorphisms of thymidylate synthase gene 5'- and 3'-UTR and gastric cancer risk: meta-analysis.Semantic proximity Read ↗

Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.